You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
CHICAGO (GenomeWeb) – NantHealth, fresh off a tough 2017 that saw the company cut 300 jobs and face a series of lawsuits related to its 2016 initial public offering, is betting on new technology and assays to carry it into the future.
360Dx Premium gives you: ✔ Full site access ✔ Interest-based email alerts ✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.